OBOOK Holdings (OWLS) operating as the OwlTing Group, announced that it has officially moved into the execution phase of its $10 million share repurchase program. The company plans to buy back shares ...
We are initiating coverage on Rocket Pharmaceuticals with a Buy rating and a $17 price target (2-3 years). The company has an enterprise value, EV, of $151M at present, a valuation that implied near ...
Purpose-built facility secures Convergent’s drug product manufacturing at the scale needed to meet late-stage CONV01-α clinical studies and commercial demand Expanded partnership designed to drive ...
Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, and NorthStar Medical Radioisotopes ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ: AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with ...
AUSTIN The Railroad Commission of Texas begins the new year with the next edition of its series of virtual Listening Sessions. Taking place on Wednesday, January 14, from noon to 1:30 p.m., the ...
EdSource · This California Teacher of the Year embraces her dwarfism as a strength At the year’s end, EdSource posed that deceptively simple question to a group of college students around California.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback